Mesoblast Ltd
MESO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001345099
No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $53.3M in total; no superinvestor holds it.
Other share classesMEOBF
Q3 2022 vs. Q2 2022
How the institutions holding Mesoblast Ltd changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 33 | 37 | +4 |
| Shares | 3.31M | 3.84M | +531.5K (+16.1%) |
| Value | $7.06M | $10.3M | +$3.25M (+46.0%) |
New holders (10)
Institutions that held Mesoblast Ltd at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ronit Capital LLP | 150,000 | $382.0K | 0.54% |
| Balyasny Asset Management LLC | 59,720 | $152.0K | 0.00% |
| Delaney Dennis R | 24,000 | $61.0K | 0.06% |
| Envestnet Asset Management Inc | 13,054 | $33.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,770 | $7.00K | 0.00% |
| Ronald Blue Trust, Inc. | 799 | $2.00K | 0.00% |
| Signaturefd, LLC | 335 | $1.00K | 0.00% |
| Wipfli Financial Advisors LLC, | 541 | $1.00K | 0.00% |
| CWM, LLC | 2 | $0 | 0.00% |
| Vident Investment Advisory, LLC | 24,889 | $0 | 0.00% |
Sold out (6)
Institutions that held Mesoblast Ltd at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Millennium Management LLC | 42,690 | $95.0K |
| Tobias Financial Advisors, Inc. | 20,000 | $44.0K |
| Wilbanks Smith & Thomas Asset Management LLC | 17,498 | $39.0K |
| Virtu Financial LLC | 12,301 | $27.0K |
| Merit Financial Group, LLC | 12,122 | $27.0K |
| National Bank of Canada | 1,400 | $3.00K |